• S&P 500: 1,342.64
  • Change: -0.69%
$40.43 0.09 (+0.22%)
2/10/2012 4:00 PM

Cubist Pharmaceuticals, Inc. (NASDAQ:CBST)

CAPS Rating: 4 out of 5

A biopharmaceutical company focused on the research, development and commercialization of pharmaceutical products that address unmet medical needs in the acute care environment.

Current Price $40.43 Mkt Cap $2.47B
Open $40.01 P/E Ratio 48.70
Prev. Close $40.34 Div. (Yield) N/A (N/A)
Daily Range $39.63 - $40.61 Volume 828,192
52-Wk Range $21.39 - $42.39 Avg. Daily Vol. 0

Caps

How do you think CBST will perform against the market?

You must Sign in to MSN Caps before you can make a call.

All Players

309 Outperform
17 Underperform
 

All-Star Players

91 Outperform
4 Underperform
 

Wall Street

14 Outperform
2 Underperform
 

Top CBST Bull/Bear Pitches

The best Bull and Bear pitches based on recency and number of recommendations.

PDTBiotech (92.86)
Submitted May 27, 2011

Comically simple speculation approach - buying the rumor, hoping to sell the news. I like Cubist a lot, but I'll hit the high points.*Rumored offer by Shire is probably legit, and will stir up BD execs at many other companies to take a peek.… More

narlinbeaty (25.71)
Submitted May 17, 2008

This company make a drung called Daptomyocin. The drug is affective against MRSA and is used internationally for skin infections and bactermia. In many ways ths drug is a heavy hitting antiboitic used has last line of defense in the hospital setting.… More

CBST VS S&P 500 (SPY)

Recent Community Commentary

Read the most recent pitches from players about CBST.

Recs

0
Member Avatar pchop123 (70.20) Submitted: 2/6/2012 4:01:45 PM : Outperform Start Price: $42.30 CBST Score: -4.56

Must own in pharma area and possible takeover

Recs

0
Member Avatar PharmaD (62.44) Submitted: 10/26/2011 11:18:24 PM : Outperform Start Price: $39.29 CBST Score: -2.37

Clear takeover target for big pharma

Recs

0
Member Avatar zzlangerhans (99.27) Submitted: 9/2/2011 11:03:52 AM : Outperform Start Price: $33.04 CBST Score: +9.19

Cubist is a tasty treat at this price. I missed an opportunity to pick them up below 30 in the depths of the recent decline - I imagine I was saving a few stocks for a deeper dip. Now that I've had time to make a more measured assessment, I see the stock as having all the ingredients for a successful mid-cap biotech/pharma outperform pick.

1. Growing revenues. Sequential quarterly numbers of 161M, 163M, and most recently 177M. Yes, all the revenues come from a single drug. But sales have been steadily growing for years and there's no generic until 2018. Cubicin was also recently approved in Japan which might give some juice to the top line.

2. Strong pipeline. Novel anti-pseudomonal cephalosporin CXA-201 has moved into phase III trials in UTI and will soon do the same with intra-abdominal infections. The company reported encouraging phase II data for c.diff antibiotic CB-183,215 in June but has not yet decided if and when to progress this candidate to a phase III trial.

3. Share price significantly off of recent highs. The share price was over 38 in June. There's only one thing bringing the stock down, and that's broad market uncertainty. When fund managers liquidate a speculative position because they can't remember what that ticker stood for, it's an opportunity for sector-focused traders to come in and pull the babies from the bathwater.

Leaderboard

Find the members with the highest scoring picks in CBST.

Score Leader

TrackJMP

TrackJMP (84.95) Score: +135.94

The Score Leader is the player with the highest score across all their picks in CBST.

Top
Pick
Member Name Member
Rating
Start
Date
Call Time
Frame
Start
Price
Stock
Gain
Index
Gain
Score Commentary
RICKDBELL 62.58 2/1/2008 Outperform 5Y $17.09 +136.57% +1.51% +135.06 0 Comment
germbuster < 20 3/24/2008 Outperform NS $17.20 +135.06% +4.52% +130.54 0 Comment
VanGundy1 27.32 1/19/2007 Outperform 5Y $17.70 +128.42% -0.20% +128.61 1 Comment
Oneofeach 43.86 6/17/2008 10/9/2011 Outperform 3M $17.68 +128.68% +2.52% +126.16 0 Comment
UtahHick < 20 2/4/2008 Outperform 1Y $18.04 +124.11% +0.59% +123.52 0 Comment
lassinator 60.76 6/17/2008 Outperform NS $18.00 +124.61% +1.76% +122.85 0 Comment
RAIDERFAN77 70.00 1/3/2007 7/8/2009 Outperform 3M $18.25 +121.53% +0.26% +121.28 0 Comment
msbdove 37.46 12/18/2006 Outperform 3Y $18.27 +121.29% +0.05% +121.24 1 Comment
Dksmoleroff < 20 6/26/2008 Outperform 5Y $17.70 +128.42% +7.33% +121.09 0 Comment
mdbnyc 82.65 2/26/2008 Outperform NS $18.16 +122.63% +2.40% +120.23 0 Comment

Wall Street

See what the Wall Street professionals think, according to their public statements and filings.

Player Name Player
Rating
Start
Date
Call Time
Frame
Start
Price
Stock
Gain
S&P
Gain
Score End Date Commentary
TrackZacks 71.09 1/11/2012 Underperform 3M $40.57 +1.97% +0.11% -1.86 1/17/2012 @ $41.37 1 Comment
TrackJimCramer 78.17 1/10/2012 Outperform 3W $40.27 +0.40% +4.05% -3.65 0 Comment
TrackNeedham 92.52 7/15/2011 Outperform NS $36.06 +12.12% +2.05% +10.07 0 Comment
TrackOppenheimer 79.13 4/20/2011 Outperform NS $32.70 +23.64% +1.11% +22.52 0 Comment
TrackZacks 71.09 4/15/2011 Outperform 3M $32.27 +7.81% -1.08% +8.89 7/18/2011 @ $34.79 1 Comment
TrackJimCramer 78.17 4/11/2011 Underperform 3W $29.78 +35.22% -2.51% -37.74 1/11/2012 @ $40.27 0 Comment
TrackRWBaird 90.56 4/5/2011 Outperform NS $29.11 +38.89% +1.02% +37.86 0 Comment
TrackZacks 71.09 1/13/2011 Underperform 3M $22.51 +28.88% +3.80% -25.08 4/5/2011 @ $29.01 1 Comment
TrackZacks 71.09 7/16/2010 Underperform 3M $21.37 +18.16% +10.89% -7.26 10/18/2010 @ $25.25 1 Comment
TrackRBCCapMkts 93.36 12/4/2009 Outperform NS $17.60 +129.72% +20.45% +109.27 0 Comment
TrackBWS 81.16 10/16/2009 Underperform NS $19.17 -6.62% +2.41% +9.04 11/16/2009 @ $17.90 0 Comment
TrackEdwardOwens 98.81 9/30/2009 Outperform NS $20.20 +100.15% +30.47% +69.68 0 Comment
TrackOppenheimer 79.13 8/6/2009 Underperform NS $20.57 -15.80% +4.33% +20.13 10/29/2009 @ $17.32 0 Comment
TrackWedbush 84.95 3/20/2009 Outperform NS $15.70 +157.52% +75.11% +82.41 0 Comment
trackthinkequity 90.22 2/20/2009 Outperform NS $17.00 +137.82% +78.26% +59.56 0 Comment
TrackLeerinkSwan 88.11 12/8/2008 Underperform NS $25.88 +56.22% +52.48% -3.74 0 Comment
TrackRodmanRen < 20 11/20/2008 Outperform NS $22.19 +82.20% +72.03% +10.17 0 Comment
trackmerriman 70.89 10/30/2008 Outperform NS $22.75 +77.71% +43.49% +34.22 0 Comment
TrackJimCramer 78.17 10/29/2008 Outperform 3W $22.35 +33.22% +42.31% -9.09 4/12/2011 @ $29.77 0 Comment
TrackNeedham 92.52 7/1/2008 Outperform NS $18.01 +39.33% +4.96% +34.37 3/31/2011 @ $25.09 0 Comment
TrackStanfordRes 85.38 1/24/2008 Outperform NS $19.07 +112.01% +4.64% +107.36 0 Comment
TrackRWBaird 90.56 1/15/2008 Outperform NS $21.50 -12.84% -24.78% +11.94 10/7/2009 @ $18.74 0 Comment
TrackStifel 96.18 7/19/2007 Outperform NS $22.85 +76.94% -8.87% +85.80 0 Comment
TrackLazardCapit 78.92 4/19/2007 Underperform NS $20.79 +9.91% +5.84% -4.07 7/19/2007 @ $22.85 0 Comment
TrackJMP 84.95 1/5/2007 Outperform NS $17.07 +136.85% +0.91% +135.94 0 Comment
TrackJefferies 84.73 10/16/2006 Outperform NS $22.62 +78.74% +4.47% +74.27 0 Comment
TrackMatrix 92.79 8/31/2006 Underperform NS $23.52 +71.90% +9.47% -62.43 0 Comment

Featured Broker Partners